Skip to search form
Skip to main content
Skip to account menu
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
riociguat 0.5 MG Oral Tablet
Known as:
RIOCIGUAT 0.5MG TAB
, RIOCIGUAT 0.5MG TAB,UD [VA Product]
, RIOCIGUAT 0.5MG TAB UD
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Guanylate Cyclase Stimulators [MoA]
Hypertensive disease
Oral Tablet
riociguat
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT)
M. Huntgeburth
,
J. Kießling
,
+4 authors
S. Rosenkranz
BMC Pharmacology and Toxicology
2015
Corpus ID: 26388594
Background Raynaud’s phenomenon (RP) is a coldor stress-triggered digital ischemia caused by vasoconstriction in the digital…
Expand
2015
2015
РИОЦИГУАТ – ПЕРВЫЙ ЛЕКАРСТВЕННЫЙ ПРЕПАРАТ ИННОВАЦИОННОГО КЛАССА СТИМУЛЯТОРОВ ГУАНИЛАТЦИКЛАЗЫ ДЛЯ ЛЕЧЕНИЯ БОЛЬНЫХ ЛЕГОЧНОЙ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ
Array Е. Чазова
,
Array В. Мартынюк
2015
Corpus ID: 78055955
Summary Pulmonary arterial hypertension (PAH) drug therapy including prostanoids, endothelin receptor antagonists, type 5…
Expand
2013
2013
Neuer Weg zur Therapie der pulmonalen Hypertonie
S. Meinrenken
2013
Corpus ID: 75940243
Fur die Therapie der pulmonalen Hypertonie (PH) steht mit den loslichen Guanylatcyclase-Stimulatoren eine neue Gruppe von…
Expand
2013
2013
Riociguat zur Therapie der inoperablen chronisch thromboembolischen pulmonalen Hypertonie: Eine randomisierte, doppelblinde, placebokontrollierte Phase-III-Studie (CHEST-1)
H. Ghofrani
,
F. Grimminger
,
+5 authors
M. M. Hoeper
2013
Corpus ID: 75792326
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE